Farbivent Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Ipratropium Br 0.5 mg, salbutamol sulphate 2.5 mg

Indications/Uses

Bronchospasm associated w/ COPD in patients on treatment w/ both ipratropium Br & salbutamol.

Dosage/Direction for Use

Adult (including elderly) 1 amp 3-4 times daily.

Contraindications

Hypersensitivity to atropine derivatives. Hypertrophic obstructive cardiomyopathy, tachyarrhythmia.

Special Precautions

Avoid contact w/ the eyes. Patients predisposed to glaucoma, insufficiently controlled DM, recent MI, severe organic heart or vascular disorders, hyperthyroidism, phaeochromocytoma, risk of narrow-angle glaucoma, prostatic hypertrophy or bladder-neck obstruction, hypoxia, cystic fibrosis. Avoid prolonged use. Pregnancy & lactation. Childn <12 yr.

Adverse Reactions

Headache, dizziness, nervousness, tachycardia, fine tremor of skeletal muscles, palpitations; potentially serious hypokalaemia; cough, local irritation; nausea, vomiting, sweating, muscle weakness & myalgia/muscle cramps. Dry mouth, dysphonia.

View ADR Monitoring Form

Drug Interactions

Xanthines, other β-adrenergics & anticholinergics; glucocorticosteroids, diuretics; digoxin; β-blockers; MAOIs, TCA; halothane, trichloroethylene, enflurane.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03AL02 - salbutamol and ipratropium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.

Regulatory Classification

Presentation/Packing

Form

Farbivent inhalation soln

Packing/Price

(amp) 2.5 mL x 10 × 1's

Farbivent

ipratropium bromide + salbutamol

Manufacturer:

Fahrenheit